SENORES PHARMACEUTICALS L (SENORES) — Net Asset Momentum

Latest YoY growth as of March 2026: +10057.7%

SENORES PHARMACEUTICALS L (SENORES) recorded a net asset momentum of 10057.7% as of March 2026, with net assets of Rs9.65 Billion INR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. For live market cap and overall valuation, see SENORES PHARMACEUTICALS L market cap and net worth.

YoY Momentum

+10057.7%
Year-over-year

Current Net Assets

Rs9.65 Billion
INR · March 2026

Years of Data

5
2022 – 2026

Country

India
NSE

SENORES PHARMACEUTICALS L Net Asset Momentum (2022–2026)

This chart tracks SENORES PHARMACEUTICALS L's year-over-year net asset growth across 5 annual reporting periods from 2022 to 2026. The most recent momentum reading is +10057.7%, with net assets of Rs9.65 Billion INR as of March 2026. See debt-free asset ratio of SENORES PHARMACEUTICALS L to measure how much of total assets are equity-financed.

Annual Net Asset History for SENORES PHARMACEUTICALS L (2022–2026)

The table below shows the complete annual net asset history for SENORES PHARMACEUTICALS L from 2022 to 2026, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check SENORES goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Year Net Assets (INR) Total Assets Total Liabilities YoY Momentum
2026 Rs9.65 Billion Rs16.04 Billion Rs6.39 Billion ▲ +10057.7%
2025 Rs94.96 Million Rs145.66 Million Rs50.70 Million ▼ -95.9%
2024 Rs2.32 Billion Rs6.22 Billion Rs3.90 Billion ▲ +409.3%
2023 Rs454.99 Million Rs1.31 Billion Rs855.54 Million ▲ +24.3%
2022 Rs365.90 Million Rs591.52 Million Rs225.62 Million